Evidence map›Paper›PMID 29098645›Full record

Trial reportNeuroscience bulletin2018

Neurocognitive Graphs of First-Episode Schizophrenia and Major Depression Based on Cognitive Features.

Sugai Liang, Roberto Vega, Xiangzhen Kong, Wei Deng, Qiang Wang, Xiaohong Ma, Mingli Li, Xun Hu, Andrew J Greenshaw, Russell Greiner and 1 more

Abstract readClinical Trial
In one paragraph

Trial report in Neuroscience bulletin, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Schizophrenia: A Survey of Artificial Intelligence Techniques Applied to Detection and Classification.International journal of environmental research and public health · 2021
    Review
  10. Histamine HNature communications · 2021
    Article
  11. Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Sugai LiangMental Health Centre, West China Hospital, Sichuan University, Chengdu, 610041, China.
Roberto VegaDepartment of Computing Science, University of Alberta, Edmonton, AB, T6G 2R7, Canada.
Xiangzhen KongLanguage and Genetics Department, Max Planck Institute for Psycholinguistics, 6525 XD, Nijmegen, The Netherlands.
Wei DengMental Health Centre, West China Hospital, Sichuan University, Chengdu, 610041, China.
Qiang WangMental Health Centre, West China Hospital, Sichuan University, Chengdu, 610041, China.
Xiaohong MaMental Health Centre, West China Hospital, Sichuan University, Chengdu, 610041, China.
Mingli LiMental Health Centre, West China Hospital, Sichuan University, Chengdu, 610041, China.
Xun HuHuaxi Biobank, West China Hospital, Sichuan University, Chengdu, 610041, China.
Andrew J GreenshawDepartment of Psychiatry, University of Alberta, Edmonton, AB, T6G 2R7, Canada.
Russell GreinerDepartment of Computing Science, University of Alberta, Edmonton, AB, T6G 2R7, Canada.
Tao LiMental Health Centre, West China Hospital, Sichuan University, Chengdu, 610041, China. litaohx@scu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neurocognitive deficits are frequently observed in patients with schizophrenia and major depressive disorder (MDD). The relations between cognitive features may be represented by neurocognitive graphs based on cognitive features, modeled as Gaussian Markov random fields. However, it is unclear whether it is possible to differentiate between phenotypic patterns associated with the differential diagnosis of schizophrenia and depression using this neurocognitive graph approach. In this study, we enrolled 215 first-episode patients with schizophrenia (FES), 125 with MDD, and 237 demographically-matched healthy controls (HCs). The cognitive performance of all participants was evaluated using a battery of neurocognitive tests. The graphical LASSO model was trained with a one-vs-one scenario to learn the conditional independent structure of neurocognitive features of each group. Participants in the holdout dataset were classified into different groups with the highest likelihood. A partial correlation matrix was transformed from the graphical model to further explore the neurocognitive graph for each group. The classification approach identified the diagnostic class for individuals with an average accuracy of 73.41% for FES vs HC, 67.07% for MDD vs HC, and 59.48% for FES vs MDD. Both of the neurocognitive graphs for FES and MDD had more connections and higher node centrality than those for HC. The neurocognitive graph for FES was less sparse and had more connections than that for MDD. Thus, neurocognitive graphs based on cognitive features are promising for describing endophenotypes that may discriminate schizophrenia from depression.

Indexed as

AlgorithmsMachine LearningAdultEndophenotypesFemaleHumansMajor Depressive DisorderMaleMarkov ChainsNeuropsychological TestsSchizophreniaYoung AdultGraphical LASSOMajor depressive disorderNeurocognitionNeurocognitive graphSchizophrenia

Identifiers

PMID29098645
PMCPMC5856717

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.